The WHO-recommended strategy of tuberculosis control: the new vision of DOTS

M. Uplekar (Geneva, Switzerland)

Source: Annual Congress 2007 - Tuberculosis control and HIV in Europe: good or bad news?
Session: Tuberculosis control and HIV in Europe: good or bad news?
Session type: Symposium
Number: 361
Disease area: Respiratory infections

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Uplekar (Geneva, Switzerland). The WHO-recommended strategy of tuberculosis control: the new vision of DOTS. Annual Congress 2007 - Tuberculosis control and HIV in Europe: good or bad news?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Results of the implementation of the WHO-recommended TB control strategy in Russia
Source: Eur Respir J 2002; 20: Suppl. 38, 368s
Year: 2002

Effects of DOTS strategy on new confirmed tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 588s
Year: 2006

The effectiveness of the national program tuberculosis control in Ukraine and the future strategy
Source: Eur Respir J 2006; 28: Suppl. 50, 130s
Year: 2006

Tuberculosis-related deaths before and after the implementation of DOTS control program
Source: Annual Congress 2007 - Epidemiological and clinical aspects of tuberculosis control
Year: 2007


New approaches for evaluation of treatment effectiveness among patients with pulmonary TB under DOTS implemented conditions
Source: Eur Respir J 2002; 20: Suppl. 38, 368s
Year: 2002

Cost-effectiveness of adding novel or group 5 interventions to a background regimen for the treatment of multidrug-resistant tuberculosis in Germany
Source: International Congress 2016 – Update on drug-resistant tuberculosis
Year: 2016

A novel nurse-led approach improves treatment completion rates for latent tuberculosis infection (LTBI) treatment
Source: International Congress 2014 – Mycobacterium tuberculosis infection: new therapeutic approaches
Year: 2014



Evaluation of new smear positive tuberculosis patients 5 years after initiation of treatment under a DOTS programme
Source: Annual Congress 2010 - Tuberculosis epidemiology
Year: 2010


Efficiency of the tuberculosis detection in the implantation of the DOTS program
Source: Eur Respir J 2007; 30: Suppl. 51, 422s
Year: 2007

Old ideas to innovate tuberculosis control: preventive treatment to achieve elimination
Source: Eur Respir J 2013; 42: 785-801
Year: 2013



TB "cross-border" - a new challenge in tuberculosis management
Source: Virtual Congress 2020 – Tuberculosis and society
Year: 2020


Drug resistance in previously treated patients of tuberculosis in pre DOTS and DOTS era and its implications
Source: Annual Congress 2009 - Tuberculosis control
Year: 2009


Gene-Xpert for rapid detection of MDR-TB in re-treatment cases;a comparison with standard culture and DST
Source: International Congress 2015 – WHO guidelines in TB and clinical practice
Year: 2015


MDR-TB guidelines: what is new on clinical management
Source: ERS Webinar 2020: MDR-TB guidelines: what is new on clinical management
Year: 2020


MDR-TB management: what is new?
Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination
Year: 2012


Results of the treatment of relapses of tuberculosis by DOTS method
Source: Eur Respir J 2001; 18: Suppl. 33, 339s
Year: 2001